Patents Assigned to Aventis Pharma
  • Derivatives of purine, their preparation process and pharmaceutical compositions containing them
    Patent number: 7208598
    Abstract: A compound of the formula wherein R is defined as in the specification, which compounds have an inhibitory effect vis-à-vis cycline-dependent kinase proteins (cdk) and are endowed with antimitotic properties.
    Type: Grant
    Filed: December 7, 2004
    Date of Patent: April 24, 2007
    Assignee: Aventis Pharma
    Inventor: Jean-Luc Haesslein
  • Aryl-heteroaromatic compounds, compositions comprising them and use
    Publication number: 20050020593
    Abstract: A series of aryl-heteroaromatic compounds, compositions comprising them and use thereof are disclosed and claimed. The present invention relates in particular to novel aryl-heteroaromatic compounds exhibiting anticancer activity, and in particular inhibitory activity with regard to tubulin polymerization.
    Type: Application
    Filed: July 23, 2004
    Publication date: January 27, 2005
    Applicant: Aventis Pharma
    Inventors: Patrick Mailliet, Alain Le-Brun, Fabienne Thompson, Gilles Tiraboschi
  • Polypeptides involved in the biosynthesis of streptogramins, nucleotide sequences coding for these polypeptides and their use
    Publication number: 20040229236
    Abstract: The invention concerns methods for preparing pristinamycin IIA or IIB.
    Type: Application
    Filed: November 20, 2003
    Publication date: November 18, 2004
    Applicant: Aventis Pharma
    Inventors: Veronique Blanc, Francis Blanche, Joerl Crouzet, Nathalie Jacoues, Patricia Lacroix, Denis Thibaut, Monique Zagorec, Laurent Debussche, Valerie De Crecy-Lagard
  • Oligosaccharides, their preparation and pharmaceutical compositions containing them
    Patent number: 6617316
    Abstract: The present invention relates to oligosaccharides of formula: to mixtures thereof, to diastereoisomers thereof, to a process for preparing them, to pharmaceutical compositions containing them, and to their use in preventing or treating a disease associated with an inflammatory process involving the production of nitric oxide.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: September 9, 2003
    Assignee: Aventis Pharma
    Inventors: Pierre Mourier, Elisabeth Perrin, Jean-marie Stutzmann, Christian Viskov, Florence Wahl